MEDICINAL AGENT AS OINTMENT FOR CUTANEOUS DISEASE AND CUTANEOUS MANIFESTATION OF IMMUNOLOGICALLY MEDIATED DISEASE TREATMENT AND/OR PROPHYLAXIS AND METHOD OF ITS SYNTHESIS Russian patent published in 1997 - IPC

Abstract RU 2079303 C1

FIELD: organic chemistry and technology. SUBSTANCE: product: tricycle compound of the formula (I) where: adjacent pairs R1 and R2, R3, and R4, R5 and R6 form other bond with carbon atoms or they mean H; R2 can be lower alkyl; R7 - hydrogen, hydroxy-group, protected hydroxy-group, lower alkoxy-group; or R7 together with R1 form oxo-group; R8 - hydrogen or hydroxy-group; R9 - lower alkyl, alkenyl or lower alkyl substituted with oxo-group; R10-R17 - independently hydrogen or lower alkyl; R18 and R19 - independently R18a

and hydrogen or R19a
and hydrogen; R18a
- hydroxy-group or lower alkoxy-group; R19a
- hydroxy-group, lower alkoxy-group or protected hydroxy-group; n = 1 or 2; x1 and x2 - hydrogen or form together oxo-group; y1 - hydrogen or hydroxy-group; y2 - hydrogen or y1 and y2 form together oxo-group. Solubilizing agent and/or agent promoting impregnation: alkanediol, lower alkylene carbonate, alkanedicarboxylic acid ester, alkanecarboxylic acid glycerol ester, higher alkanecarboxylic acid alkyl ether, higher unsaturated alcohol and azacycloalkane. Ointment has tricycle compound or its pharmaceutically acceptable salt, solubilizing agent or agent promoting impregnation and ointment base taken at ratio, wt.-%: 0.01-10; 1-30 and the balance, up to 100%. Active component is dissolved in solubilizing agent or agent promoting impregnation, solution is mixed with an ointment base. EFFECT: improved method of synthesis, enhanced effectiveness of treatment and prophylaxis. 8 cl

Similar patents RU2079303C1

Title Year Author Number
IMMUNOSUPPRESSIVE COMPOSITION AND A METHOD OF ITS SYNTHESIS 1991
  • Sotoo Asakura[Jp]
  • Mitijo Fukae[Jp]
  • Sigeo Nakanisi[Jp]
  • Jasuto Kojama[Jp]
  • Joukhei Kijota[Jp]
RU2084222C1
PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE AND ANTIMICROBIAL ACTIVITIES 1991
  • Sotoo Asakura[Jp]
  • Jasuto Kojama[Jp]
  • Eukhej Kieta[Jp]
  • Kieko Akasi[Jp]
  • Akira Kagajama[Jp]
  • Esio Murakami[Jp]
  • Tosiomi Nakate[Jp]
RU2079304C1
PHARMACEUTICAL SOLUTION 1991
  • Sigeo Nakanisi[Jp]
  • Ivao Jamanaka[Jp]
RU2028142C1
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1992
  • Tokhru Kino[Jp]
  • Motoaki Nisikava[Jp]
  • Masami Izaki[Jp]
  • Sumio Kijoto[Jp]
RU2043365C1
METHOD OF SYNTHESIS OF THIAZOLE DERIVATIVES OR THEIRS SALTS WITH HALOID ACID 1990
  • Masaaki Matsuo[Jp]
  • Takasi Ogino[Jp]
  • Norikhiro Igari[Jp]
  • Khatiro Seno[Jp]
  • Kioiti Simomura[Jp]
RU2010026C1
PHARMACEUTICAL COMPOSITION 1999
  • Ibuki Rinta
  • Simodzo Fumio
  • Ueda Satosi
  • Tojoda Tosikhiko
  • Jamanaka Masajuki
  • Josida Erika
RU2203058C2
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ 1991
  • Masaaki Matsuo[Jp]
  • Dajdziro Khagivara[Jp]
  • Khirosi Mijake[Jp]
RU2073683C1
OCTANE OXASPIRO [2,5]DERIVATIVE AND PROCESS FOR PREPARATION THEREOF (VARIANTS) 1989
  • Teruo Oku[Jp]
  • Tiesi Kasakhara[Jp]
  • Takekhiko Okhkava[Jp]
  • Masasi Khasimoto[Jp]
RU2068412C1
MEDICINAL COMPOSITIONS 1997
  • Khata Takekhisa
  • Tokunaga Judzi
  • Simodzo Fumio
  • Kimura Sumikhisa
  • Khirose Takeo
  • Ueda Satosi
RU2197226C2
PREPARATION FOR TOPICAL USE FOR IMMUNOSUPPRESSION AND TREATMENT OF AUTOIMMUNE AND ALLERGIC DISEASES 1996
  • Tsuneo Fudzii
  • Tadasi Misina
  • Kodzi Tesima
  • Tomonori Imaesi
RU2156127C2

RU 2 079 303 C1

Authors

Sotoo Asakura[Jp]

Josio Murakami[Jp]

Nobuto Kanagava[Jp]

Tosiomi Nakate[Jp]

Dates

1997-05-20Published

1991-09-03Filed